G. Bellis and L. Lemonnier, Registre français de la mucoviscidose, 2012.

A. Adler, B. Shine, P. Chamnan, C. Haworth, and D. Bilton, Genetic Determinants and Epidemiology of Cystic Fibrosis-Related Diabetes: Results from a British cohort of children and adults, Diabetes Care, vol.31, issue.9, pp.1789-94, 2008.
DOI : 10.2337/dc08-0466

D. Blic, J. Delacourt, and C. , Pneumologie pédiatrique. Medecine -Sciences Flammarion, 2009.

C. Koch, H. Cuppens, M. Rainisio, U. Madessani, H. Harms et al., European Epidemiologic Registry of Cystic Fibrosis (ERCF): Comparison of major disease manifestations between patients with different classes of mutations, Pediatric Pulmonology, vol.122, issue.1, pp.1-12, 2001.
DOI : 10.1002/1099-0496(200101)31:1<1::AID-PPUL1000>3.0.CO;2-T

A. Moran, D. Hardin, D. Rodman, H. Allen, R. Beall et al., Diagnosis, screening and management of cystic fibrosis related diabetes mellitus, Diabetes Research and Clinical Practice, vol.45, issue.1, pp.61-73, 1999.
DOI : 10.1016/S0168-8227(99)00058-3

M. Costa, S. Potvin, Y. Berthiaume, L. Gauthier, A. Jeanneret et al., Diabetes: a major co-morbidity of cystic fibrosis, Diabetes & Metabolism, vol.31, issue.3, pp.221-253, 2005.
DOI : 10.1016/S1262-3636(07)70189-1

P. Noone and M. Knowles, CFTR-opathies " : disease phenotypes associated with cystic fibrosis transmembrane regulator gene mutations, Respiratory Research, vol.2, issue.6, p.328, 2001.
DOI : 10.1186/rr82

A. Khammar, N. Stremler, J. Dubus, G. Gross, J. Sarles et al., Value of continuous glucose monitoring in screening for diabetes in cystic fibrosis] Holter glycémique et dépistage du diabète chez l'enfant atteint de mucoviscidose. Arch Pédiatrie Organe Off Sociéte Fr Pédiatrie, pp.1540-1546, 2009.

B. Marshall, S. Butler, M. Stoddard, A. Moran, T. Liou et al., Epidemiology of cystic fibrosis-related diabetes, The Journal of Pediatrics, vol.146, issue.5, pp.681-688, 2005.
DOI : 10.1016/j.jpeds.2004.12.039

S. Lanng, B. Thorsteinsson, J. Nerup, and C. Koch, Diabetes mellitus in cystic fibrosis: effect of insulin therapy on lung function and infections, Acta Paediatrica, vol.82, issue.8, pp.849-53, 19921994.
DOI : 10.1007/BF02428297

A. Moran, L. Doherty, X. Wang, and W. Thomas, Abnormal glucose metabolism in cystic fibrosis, The Journal of Pediatrics, vol.133, issue.1, pp.10-17, 1998.
DOI : 10.1016/S0022-3476(98)70171-4

C. Milla, J. Billings, and A. Moran, Diabetes Is Associated With Dramatically Decreased Survival in Female but Not Male Subjects With Cystic Fibrosis, Diabetes Care, vol.28, issue.9, pp.2141-2145, 2005.
DOI : 10.2337/diacare.28.9.2141

S. Lanng, B. Thorsteinsson, J. Nerup, and C. Koch, Influence of the development of diabetes mellitus on clinical status in patients with cystic fibrosis, European Journal of Pediatrics, vol.727, issue.Suppl 1, pp.684-691, 1992.
DOI : 10.1007/BF01957574

S. Tofe, J. Moreno, L. Maiz, M. Alonso, H. Escobar et al., Insulin-secretion abnormalities and clinical deterioration related to impaired glucose tolerance in cystic fibrosis, European Journal of Endocrinology, vol.152, issue.2, pp.241-248, 2005.
DOI : 10.1530/eje.1.01836

E. Bismuth, K. Laborde, P. Taupin, G. Velho, V. Ribault et al., Glucose Tolerance and Insulin Secretion, Morbidity, and Death in Patients with Cystic Fibrosis, The Journal of Pediatrics, vol.152, issue.4, 2008.
DOI : 10.1016/j.jpeds.2007.09.025

P. Chamnan, B. Shine, C. Haworth, D. Bilton, and A. Adler, Diabetes as a Determinant of Mortality in Cystic Fibrosis, Diabetes Care, vol.33, issue.2, pp.311-317, 2010.
DOI : 10.2337/dc09-1215

S. Finkelstein, C. Wielinski, G. Elliott, W. Warwick, J. Barbosa et al., Diabetes mellitus associated with cystic fibrosis, The Journal of Pediatrics, vol.112, issue.3, pp.373-380, 1988.
DOI : 10.1016/S0022-3476(88)80315-9

A. Moran, J. Dunitz, B. Nathan, A. Saeed, B. Holme et al., Cystic Fibrosis-Related Diabetes: Current Trends in Prevalence, Incidence, and Mortality, Diabetes Care, vol.32, issue.9, pp.1626-1657, 2009.
DOI : 10.2337/dc09-0586

A. Brennan, D. Geddes, K. Gyi, and E. Baker, Clinical importance of cystic fibrosis-related diabetes, Journal of Cystic Fibrosis, vol.3, issue.4, pp.209-231, 2004.
DOI : 10.1016/j.jcf.2004.08.001

K. Ode and A. Moran, New insights into cystic fibrosis-related diabetes in children, The Lancet Diabetes & Endocrinology, vol.1, issue.1, pp.52-60, 2013.
DOI : 10.1016/S2213-8587(13)70015-9

D. Hardin, A. Leblanc, G. Marshall, and D. Seilheimer, Mechanisms of Insulin Resistance in Cystic Fibrosis ??? 437, Pediatric Research, vol.22, pp.1022-1030, 2001.
DOI : 10.1203/00006450-199804001-00458

S. Lanng, B. Thorsteinsson, M. Røder, J. Nerup, and C. Koch, Insulin sensitivity and insulin clearance in cystic fibrosis patients with normal and diabetic glucose tolerance, Clinical Endocrinology, vol.5, issue.2, pp.217-240, 1994.
DOI : 10.1007/BF00260951

S. Blackman, S. Hsu, S. Ritter, K. Naughton, F. Wright et al., A susceptibility gene for type 2 diabetes confers substantial risk for diabetes complicating cystic fibrosis, Diabetologia, vol.359, issue.13, pp.1858-65, 2009.
DOI : 10.1007/s00125-009-1436-2

A. Stecenko, Why hyperglycemia is bad-link between glucose, oxidative stress and inflammation, p.2012

M. Castanet and M. Wieliczko, Les complications endocriniennes de la mucoviscidose chez l'enfant, Archives de P??diatrie, vol.19, pp.27-36, 2012.
DOI : 10.1016/S0929-693X(12)71105-3

J. Gregory, What are the main research findings during the last 5 years that have changed my clinical practice in diabetes medicine?, Archives of Disease in Childhood, vol.97, issue.5, pp.436-445, 2012.
DOI : 10.1136/adc.2011.300710

O. Riordan, S. Robinson, P. Donaghue, K. Moran, and A. , Management of cystic fibrosis-related diabetes, Pediatric Diabetes, vol.106, issue.Suppl. 1, pp.338-382, 2008.
DOI : 10.1111/j.1399-5448.2008.00437.x

C. Milla, W. Warwick, and A. Moran, Trends in Pulmonary Function in Patients with Cystic Fibrosis Correlate with the Degree of Glucose Intolerance at Baseline, American Journal of Respiratory and Critical Care Medicine, vol.162, issue.3, pp.891-896, 2000.
DOI : 10.1164/ajrccm.162.3.9904075

A. Brennan, K. Gyi, D. Wood, J. Johnson, R. Holliman et al., Airway glucose concentrations and effect on growth of respiratory pathogens in cystic fibrosis, Journal of Cystic Fibrosis, vol.6, issue.2, 2007.
DOI : 10.1016/j.jcf.2006.03.009

K. Konrad, A. Thon, M. Fritsch, E. Frohlich-reiterer, E. Lilienthal et al., Comparison of Cystic Fibrosis-Related Diabetes With Type 1 Diabetes Based on a German/Austrian Pediatric Diabetes Registry, Diabetes Care, vol.36, issue.4, pp.879-86, 2013.
DOI : 10.2337/dc12-0807

E. Kerem, S. Conway, S. Elborn, H. Heijerman, and C. Committee, Standards of care for patients with cystic fibrosis: a European consensus, Journal of Cystic Fibrosis, vol.4, issue.1, pp.7-26, 2005.
DOI : 10.1016/j.jcf.2004.12.002

P. Middleton, M. Wagenaar, A. Matson, M. Craig, D. Holmes-walker et al., Australian standards of care for cystic fibrosis-related diabetes, Respirology, vol.7, issue.Suppl. 12, pp.185-92, 2014.
DOI : 10.1111/resp.12227

A. Moran, C. Brunzell, R. Cohen, M. Katz, B. Marshall et al., Clinical Care Guidelines for Cystic Fibrosis-Related Diabetes: A position statement of the American Diabetes Association and a clinical practice guideline of the Cystic Fibrosis Foundation, endorsed by the Pediatric Endocrine Society, Diabetes Care, vol.33, issue.12, pp.2697-708, 2010.
DOI : 10.2337/dc10-1768

E. Mozzillo, A. Franzese, G. Valerio, A. Sepe, D. Simone et al., One-year glargine treatment can improve the course of lung disease in children and adolescents with cystic fibrosis and early glucose derangements, Pediatric Diabetes, vol.147, issue.Suppl. 2, pp.162-169, 2009.
DOI : 10.1111/j.1399-5448.2008.00451.x

K. Mohan, K. Israel, H. Miller, R. Grainger, M. Ledson et al., Long-Term Effect of Insulin Treatment in Cystic Fibrosis-Related Diabetes, Respiration, vol.76, issue.2, pp.181-187, 2008.
DOI : 10.1159/000110206

A. Moran, P. Pekow, P. Grover, M. Zorn, B. Slovis et al., Insulin Therapy to Improve BMI in Cystic Fibrosis-Related Diabetes Without Fasting Hyperglycemia: Results of the Cystic Fibrosis Related Diabetes Therapy Trial, Diabetes Care, vol.32, issue.10, pp.1783-1791, 2009.
DOI : 10.2337/dc09-0585

B. Yung, A. Landers, B. Mathalone, K. Gyi, and M. Hodson, Diabetic retinopathy in adult patients with cystic fibrosis-related diabetes, Respiratory Medicine, vol.92, issue.6, pp.871-873, 1998.
DOI : 10.1016/S0954-6111(98)90390-0

S. Schwarzenberg, W. Thomas, T. Olsen, T. Grover, D. Walk et al., Microvascular Complications in Cystic Fibrosis-Related Diabetes, Diabetes Care, vol.30, issue.5, pp.1056-61, 2007.
DOI : 10.2337/dc06-1576

J. Van-den-berg, A. Morton, S. Kok, H. Pijl, S. Conway et al., Microvascular complications in patients with cystic fibrosis-related diabetes (CFRD), Journal of Cystic Fibrosis, vol.7, issue.6, pp.515-524, 2008.
DOI : 10.1016/j.jcf.2008.05.008

O. Riordan, S. Dattani, M. Hindmarsh, and P. , Cystic Fibrosis-Related Diabetes in Childhood, Hormone Research in Paediatrics, vol.73, issue.1, pp.15-24, 2010.
DOI : 10.1159/000271912

L. Minicucci, M. Haupt, R. Casciaro, A. De-alessandri, F. Bagnasco et al., Slow-release insulin in cystic fibrosis patients with glucose intolerance: a randomized clinical trial, Pediatric Diabetes, vol.10, issue.Suppl. 12, pp.197-202, 2012.
DOI : 10.1111/j.1399-5448.2011.00810.x

J. Haesebaert, S. Bourdy, M. Perceval, C. Chabloz, R. Nove-josserand et al., D??pistage et prise en charge des troubles du m??tabolisme glucidique chez les patients atteints de mucoviscidose. ??tude de pratiques au sein du r??seau EMERA, Archives de P??diatrie, vol.16, issue.11, pp.1435-1477, 2009.
DOI : 10.1016/j.arcped.2009.07.025

S. Lanng, A. Hansen, B. Thorsteinsson, J. Nerup, and C. Koch, Glucose tolerance in patients with cystic fibrosis: five year prospective study, BMJ, vol.311, issue.7006, pp.655-664, 1995.
DOI : 10.1136/bmj.311.7006.655

A. Sterescu, B. Rhodes, R. Jackson, A. Dupuis, A. Hanna et al., Natural History of Glucose Intolerance in Patients with Cystic Fibrosis: Ten-Year Prospective Observation Program, The Journal of Pediatrics, vol.156, issue.4, pp.613-620, 2010.
DOI : 10.1016/j.jpeds.2009.10.019

N. Scheuing, R. Holl, G. Dockter, K. Fink, S. Junge et al., Diabetes in Cystic Fibrosis: Multicenter Screening Results Based on Current Guidelines, PLoS ONE, vol.35, issue.12, 2013.
DOI : 10.1371/journal.pone.0081545.t002

J. Brodsky, S. Dougherty, R. Makani, R. Rubenstein, and A. Kelly, Elevation of 1-Hour Plasma Glucose During Oral Glucose Tolerance Testing Is Associated With Worse Pulmonary Function in Cystic Fibrosis, Diabetes Care, vol.34, issue.2, pp.292-297, 2011.
DOI : 10.2337/dc10-1604

M. Rayas, D. Willey-courand, J. Lynch, and J. Guajardo, Improved screening for cystic fibrosis-related diabetes by an integrated care team using an algorithm, Pediatric Pulmonology, vol.34, issue.10, 2014.
DOI : 10.1002/ppul.22988

H. Mosnier-pudar, Question 4 Quelles strategies diagnostiques et th??rapeutiques des troubles du metabolisme glucidique au cours de la mucoviscidose? Diab??te de la mucoviscidose : physiopathologie et crit??res diagnostiques des troubles du m??tabolisme glucidique, Archives de P??diatrie, vol.10, pp.462-468, 2003.
DOI : 10.1016/S0929-693X(03)90012-1

A. Godbout, I. Hammana, S. Potvin, D. Mainville, R. A. Berthiaume et al., No relationship between mean plasma glucose and glycated haemoglobin in patients with cystic fibrosis-related diabetes, Diabetes & Metabolism, vol.34, issue.6, pp.568-73, 2008.
DOI : 10.1016/j.diabet.2008.05.010

K. Ode, B. Frohnert, T. Laguna, J. Phillips, B. Holme et al., Oral glucose tolerance testing in children with cystic fibrosis, Pediatric Diabetes, vol.8, issue.Suppl.14, pp.487-92, 2010.
DOI : 10.1111/j.1399-5448.2009.00632.x

D. Borowitz, K. Robinson, M. Rosenfeld, S. Davis, K. Sabadosa et al., Cystic Fibrosis Foundation Evidence-Based Guidelines for Management of Infants with Cystic Fibrosis, The Journal of Pediatrics, vol.155, issue.6, 2009.
DOI : 10.1016/j.jpeds.2009.09.001

V. Stallings, L. Stark, K. Robinson, A. Feranchak, and H. Quinton, Evidence-Based Practice Recommendations for Nutrition-Related Management of Children and Adults with Cystic Fibrosis and Pancreatic Insufficiency: Results of a Systematic Review, Journal of the American Dietetic Association, vol.108, issue.5, pp.832-841, 2008.
DOI : 10.1016/j.jada.2008.02.020

R. Noronha, . De, L. Calliari, N. Damaceno, L. Muramatu et al., Update on diagnosis and monitoring of cystic fibrosis-related diabetes mellitus (CFRD), Arquivos Brasileiros de Endocrinologia & Metabologia, vol.55, issue.8, pp.613-634, 2011.
DOI : 10.1590/S0004-27302011000800016

B. Balzer, C. Graham, M. Craig, H. Selvadurai, K. Donaghue et al., Low Glycaemic Index Dietary Interventions in Youth with Cystic Fibrosis: A Systematic Review and Discussion of the Clinical Implications, Nutrients, vol.4, issue.12, pp.286-96, 2012.
DOI : 10.3390/nu4040286

M. Sunni, M. Bellin, and A. Moran, Exogenous insulin requirements do not differ between youth and adults with cystic fibrosis related diabetes, Pediatric Diabetes, vol.10, issue.Suppl. 12, pp.295-303, 2013.
DOI : 10.1111/pedi.12014

B. Yung, F. Noormohamed, M. Kemp, J. Hooper, A. Lant et al., Cystic fibrosis-related diabetes: the role of peripheral insulin resistance and ??-cell dysfunction, Diabetic Medicine, vol.19, issue.3, pp.221-227, 2002.
DOI : 10.1046/j.1464-5491.2002.00666.x

D. Elder, J. Wooldridge, L. Dolan, D. Alessio, and D. , Glucose Tolerance, Insulin Secretion, and Insulin Sensitivity in Children and Adolescents with Cystic Fibrosis and No Prior History of Diabetes, The Journal of Pediatrics, vol.151, issue.6, 2007.
DOI : 10.1016/j.jpeds.2007.05.012

D. Hardin, A. Leblanc, S. Lukenbough, and D. Seilheimer, Insulin resistance is associated with decreased clinical status in cystic fibrosis, The Journal of Pediatrics, vol.130, issue.6, pp.948-56, 1997.
DOI : 10.1016/S0022-3476(97)70282-8

A. Moran, K. Pyzdrowski, J. Weinreb, B. Kahn, S. Smith et al., Insulin Sensitivity in Cystic Fibrosis, Diabetes, vol.43, issue.8, pp.1020-1026, 1994.
DOI : 10.2337/diab.43.8.1020

S. Hameed, J. Morton, P. Field, Y. Belessis, T. Yoong et al., Once daily insulin detemir in cystic fibrosis with insulin deficiency, Archives of Disease in Childhood, vol.97, issue.5, pp.464-471, 2010.
DOI : 10.1136/adc.2010.204636

L. Dobson, A. Hattersley, S. Tiley, S. Elworthy, P. Oades et al., Clinical improvement in cystic fibrosis with early insulin treatment, Archives of Disease in Childhood, vol.87, issue.5, pp.430-431, 2002.
DOI : 10.1136/adc.87.5.430

E. Laursen, A. Juul, S. Lanng, N. Høiby, C. Koch et al., Diminished concentrations of insulin-like growth factor I in cystic fibrosis., Archives of Disease in Childhood, vol.72, issue.6, pp.494-501, 1995.
DOI : 10.1136/adc.72.6.494

D. Suratwala, J. Chan, A. Kelly, L. Meltzer, P. Gallagher et al., Nocturnal saturation and glucose tolerance in children with cystic fibrosis, Thorax, vol.66, issue.7, pp.574-582, 2011.
DOI : 10.1136/thx.2010.142141

A. Adler, B. Shine, C. Haworth, L. Leelarathna, and D. Bilton, Hyperglycemia and Death in Cystic Fibrosis-Related Diabetes, Diabetes Care, vol.34, issue.7, pp.1577-1585, 2011.
DOI : 10.2337/dc10-2289

A. Moran, J. Phillips, and C. Milla, Insulin and Glucose Excursion Following Premeal Insulin Lispro or Repaglinide in Cystic Fibrosis-Related Diabetes, Diabetes Care, vol.24, issue.10, pp.1706-1716, 2001.
DOI : 10.2337/diacare.24.10.1706

B. Schultz, A. Deroos, C. Venglarik, A. Singh, R. Frizzell et al., Glibenclamide blockade of CFTR chloride channels, Am J Physiol, vol.271, pp.192-200, 1996.

M. Bellin, T. Laguna, J. Leschyshyn, W. Regelmann, J. Dunitz et al., Insulin secretion improves in cystic fibrosis following ivacaftor correction of CFTR: a small pilot study, Pediatric Diabetes, vol.7, issue.Suppl 1, pp.417-438, 2013.
DOI : 10.1111/pedi.12026

A. Olivier, Y. Yi, X. Sun, H. Sui, B. Liang et al., Abnormal endocrine pancreas function at birth in cystic fibrosis ferrets, Journal of Clinical Investigation, vol.122, issue.10, pp.3755-68, 2012.
DOI : 10.1172/JCI60610DS1

A. Kelly and A. Moran, Update on cystic fibrosis-related diabetes, Journal of Cystic Fibrosis, vol.12, issue.4, pp.318-349, 2013.
DOI : 10.1016/j.jcf.2013.02.008

E. Succurro, M. Marini, F. Arturi, A. Grembiale, M. Lugarà et al., Elevated one-hour post-load plasma glucose levels identifies subjects with normal glucose tolerance but early carotid atherosclerosis, Atherosclerosis, vol.207, issue.1, pp.245-254, 2009.
DOI : 10.1016/j.atherosclerosis.2009.04.006

L. Dobson, C. Sheldon, and A. Hattersley, Conventional measures underestimate glycaemia in cystic fibrosis patients, Diabetic Medicine, vol.118, issue.7, pp.691-697, 2004.
DOI : 10.1111/j.1464-5491.2004.01219.x

F. Moreau, M. Weiller, V. Rosner, L. Weiss, M. Hasselmann et al., Continuous Glucose Monitoring in Cystic Fibrosis Patients According to the Glucose Tolerance, Hormone and Metabolic Research, vol.40, issue.07, pp.502-508, 2008.
DOI : 10.1055/s-2008-1062723

A. Franzese, G. Valerio, P. Buono, M. Spagnuolo, A. Sepe et al., Continuous Glucose Monitoring System in the Screening of Early Glucose Derangements in Children and Adolescents with Cystic Fibrosis, Journal of Pediatric Endocrinology and Metabolism, vol.21, issue.2, pp.109-125, 2008.
DOI : 10.1515/JPEM.2008.21.2.109

S. Hameed, J. Morton, A. Jaffé, P. Field, Y. Belessis et al., Early Glucose Abnormalities in Cystic Fibrosis Are Preceded by Poor Weight Gain, Diabetes Care, vol.33, issue.2, pp.221-227, 2010.
DOI : 10.2337/dc09-1492

A. Leclercq, B. Gauthier, V. Rosner, L. Weiss, F. Moreau et al., Early assessment of glucose abnormalities during continuous glucose monitoring associated with lung function impairment in cystic fibrosis patients, Journal of Cystic Fibrosis, vol.13, issue.4, pp.478-84, 2014.
DOI : 10.1016/j.jcf.2013.11.005

J. Widger, S. Ranganathan, and P. Robinson, Progression of structural lung disease on CT scans in children with cystic fibrosis related diabetes, Journal of Cystic Fibrosis, vol.12, issue.3, pp.216-237, 2013.
DOI : 10.1016/j.jcf.2012.09.005

A. Kern and A. Prestridge, Improving Screening for Cystic Fibrosis-Related Diabetes at a Pediatric Cystic Fibrosis Program, PEDIATRICS, vol.132, issue.2, pp.512-520, 2013.
DOI : 10.1542/peds.2012-4029

N. Waugh, P. Royle, I. Craigie, V. Ho, L. Pandit et al., Screening for cystic fibrosisrelated diabetes: a systematic review, Health Technol Assess Winch Engl, vol.16, pp.1-179, 2012.